Numerous in vitro and in vivo studies have shown that GH signaling exacerbates chemotherapy resistance and promotes cancer cell invasiveness in tumors through the upregulation of ABC transporters and EMT-associated markers [8,12,14,37,55]. Here, GH1 is linked to cancer.